Eric Patzer
Founder at ARIDIS PHARMACEUTICALS, INC.
Net worth: 54 766 $ as of 2024-03-30
Profile
Eric J.
Patzer is the founder of Aridis Pharmaceuticals, Inc. (founded in 2003) and holds the title of Executive Chairman.
He is currently a Director at FluGen, Inc. and Shenzhen Arimab Biopharmaceuticals Co., Ltd.
Eric's former positions include Vice President-Development at Genentech, Inc. (1981-1996), MedImmune Vaccines, Inc. (1996-2002), and Aviron, Inc. (Pennsylvania) (1996-2002).
He obtained a doctorate degree from the University of Virginia and an undergraduate degree from The Pennsylvania State University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2023-11-01 | 702,132 ( 1.58% ) | 54 766 $ | 2024-03-30 |
Eric Patzer active positions
Companies | Position | Start |
---|---|---|
ARIDIS PHARMACEUTICALS, INC. | Founder | 2002-12-31 |
FluGen, Inc.
FluGen, Inc. Pharmaceuticals: MajorHealth Technology Flugen, Inc. develops and produces influenza vaccines. Its products include a live attenuated vaccine candidate, a cell-line technology that provides vaccine production efficiency and capacity, and a novel, vaccine-loaded intradermal delivery technology. The company was founded by Yoshihiro Kawaoka, Gabriele Neumann and Paul Radspinner in 2007 and is headquartered in Madison, WI. | Director/Board Member | - |
Shenzhen Arimab Biopharmaceuticals Co., Ltd. | Director/Board Member | - |
Former positions of Eric Patzer
Companies | Position | End |
---|---|---|
MedImmune Vaccines, Inc.
MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA | Corporate Officer/Principal | 2001-12-31 |
Aviron, Inc. (Pennsylvania) | Corporate Officer/Principal | 2001-12-31 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 1995-12-31 |
Training of Eric Patzer
University of Virginia | Doctorate Degree |
The Pennsylvania State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ARIDIS PHARMACEUTICALS, INC. | Health Technology |
Private companies | 5 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
MedImmune Vaccines, Inc.
MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA | Health Technology |
FluGen, Inc.
FluGen, Inc. Pharmaceuticals: MajorHealth Technology Flugen, Inc. develops and produces influenza vaccines. Its products include a live attenuated vaccine candidate, a cell-line technology that provides vaccine production efficiency and capacity, and a novel, vaccine-loaded intradermal delivery technology. The company was founded by Yoshihiro Kawaoka, Gabriele Neumann and Paul Radspinner in 2007 and is headquartered in Madison, WI. | Health Technology |
Aviron, Inc. (Pennsylvania) | |
Shenzhen Arimab Biopharmaceuticals Co., Ltd. |
- Stock Market
- Insiders
- Eric Patzer